MARCIN VON GROTTHUSS, Principal Scientist, Investigative Toxicology, Takeda Pharmaceuticals

Principal Scientist in Investigative Toxicology with 20 years of experience executing multidisciplinary translational projects, including 8 years contribution to pioneering research on the analysis of clinical, molecular, and genomic data for drug development and safety evaluation for rare and common diseases, and precision medicine applications, initially, at The Broad Institute of MIT and Harvard and, currently, at Takeda Pharmaceuticals. Marcin von Grotthuss received a Ph.D. in bioinformatics at Radboud University Nijmegen, Netherlands, and gained professional experiences at Sanford-Burnham Institute (La Jolla), University of Washington (Seattle), Harvard University, University of Cambridge (UK), University of California Irvine, and the Brigham and Women’s Hospital / Harvard Medical School.